Home > Drug List > Capmatinib > Indications of Capmatinib

Indications of Capmatinib

Capmatinib is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation that leads to mesenchymal-epithelial transition (MET) exon 14 skipping as detected by an FDA-approved test.

from FDA,2023.03

Recommended Articles

Related Articles

  • The price of generic capmatinib in Laos

    The price of generic capmatinib in LaosCapmatinib has been approved for the treatment of MET exon 14-mutated non-small cell lung cancer based on demonstrated efficacy in a patient ···【more】
    Article source:Lucius LaosRelease date:2024-11-25Recommended:113

  • There are several generic versions of the Laos Lucius version of capmatinib

    There are several generic versions of the Laos Lucius version of capmatinibMET dysregulation occurs in up to 26% of patients with non-small cell lung cancer (NSCLC) after treatment···【more】
    Article source:Lucius LaosRelease date:2024-11-25Recommended:118

  • What diseases can be treated with capmatinib?

    Capmatinib acts as a targeted therapy to stop the growth and spread of cancer cells by inhibiting MET tyrosine kinase activity. Usually, this medication is for those who do not res···【more】
    Article source:Lucius LaosRelease date:2024-08-07Recommended:118

  • Who is capmatinib suitable for?

    Capmatinib is a targeted drug manufactured by Novartis for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with mesenchymal-epithelial transition···【more】
    Article source:Lucius LaosRelease date:2024-08-07Recommended:122

  • Who are the suitable populations for capmatinib?

    Capmatinib prevents the growth and spread of cancer cells by inhibiting MET tyrosine kinase activity. Usually this medication is indicated for those patients who do not respond to ···【more】
    Article source:Lucius LaosRelease date:2024-08-06Recommended:143

Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.

Contact US

Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos

E-mail:laoslucius@gmail.com

Whatsapp:

ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved